Thursday, 29 April 2021
Department of Health
154. To ask the Minister for Health his views on media reports in relation to the adverse effects of epilim on some women; if he will meet with the women and their representatives; if he will publish the HSE valproate response project report; and if he will make a statement on the matter. [22529/21]
I am fully aware of the issues surrounding sodium valproate (Epilim) and its potential effects on children whose mothers may have taken this drug during pregnancy. I met with two patient representative groups to discuss these issues in November 2020. A decision to publish the HSE's Valproate Response Project report is a matter for the HSE; however, I understand that the report has been made available to the patient groups and other interested stakeholders.